keyboard_arrow_up

Vaginal Atrophy (Atrophic Vaginitis) Market and Pipeline Review, H1 2015

RnRMarketResearch.com adds ‘Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2015’ to its store. This report Pipeline Review, H1 2015', provides an overview of the Vaginal Atrophy (Atrophic Vaginitis)'s therapeutic pipeline.

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2015 provides comprehensive information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis) and special features on late-stage and discontinued projects.

Get a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=392675 . (This is a premium report price at US$2000 for a single user PDF license)

Scope

The report provides a snapshot of the global therapeutic landscape of Vaginal Atrophy (Atrophic Vaginitis)

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

A review of the Vaginal Atrophy (Atrophic Vaginitis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Vaginal Atrophy (Atrophic Vaginitis) pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Table of Contents:

Introduction 6
Global Markets Direct Report Coverage 6
Vaginal Atrophy (Atrophic Vaginitis) Overview 7
Therapeutics Development 8
Pipeline Products for Vaginal Atrophy (Atrophic Vaginitis) - Overview 8
Pipeline Products for Vaginal Atrophy (Atrophic Vaginitis) - Comparative Analysis 9
Vaginal Atrophy (Atrophic Vaginitis) - Therapeutics under Development by Companies 10
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Vaginal Atrophy (Atrophic Vaginitis) - Products under Development by Companies 14
Vaginal Atrophy (Atrophic Vaginitis) - Companies Involved in Therapeutics Development 15

 Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.